Capital Markets, SVB, Foot & Ankle Innovation
Startup capital is the fuel for innovation in foot and ankle surgery. There are several sources for capital with debt financing through banks representing one of them. Competition is good and the more banks willing to lend the more likely that new concepts, products, and creativity will appear in our operating rooms. But if there is trouble brewing in the capital markets, startup capital will become more difficult, and more expensive, to come by.
Silicon Valley Bank (SVB)
SVB was not a common name in the Orthopedic sector before last week. Now you'd have to be living under a rock to have missed its Twitter-fueled collapse.
Foot & Ankle and SVB
Nothing negative here for our industry. While Treace Medical had a relationship with SVB, by this report it has had no negative exposure to the collapse.
Recent Posts
See AllAccessing and sharing information has never been easier. Dr. Selene Parekh is doing his part to foster connections for educational...
by Vince Vacketta, DPM Medical malpractice litigation is an unfortunate aspect of any physician’s or surgeon's practice. Orthopedic...
Foot Innovate held its Leadership Conference in Dallas from June 6-8, 2024. Chairman Mark Easley and the Foot Innovate leadership team of...
Opmerkingen